Alliances
Sanofi Pasteur and Translate Bio announced the expansion of an existing collaboration to develop mRNA vaccines for infectious diseases. The original deal was entered in 2018.
Sarepta Therapeutics entered into a research alliance with Codiak BioSciences to design and develop engineered exosome therapeutics for neuromuscular diseases.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 22, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 19, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 17, 2020.
Neurocrine Biosciences is partnering with Japan’s Takeda Pharmaceutical to develop and commercialize molecules in Takeda’s early-to-mid-stage psychiatry pipeline.
The two companies will explore potential oncology treatments with emerging technology.
The goal is to evaluate the potential use of MGTA-117, Magenta’s novel targeted antibody drug conjugate (ADC) for the conditioning of patients with sickle cell disease and beta-thalassemia.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 15, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 12, 2020.
PRESS RELEASES